Dunlee unveiled its new oncology bundles for the first time this year, launched at the 2022 European Congress of Radiology

July 25, 2022 —Dunleeunveiled its new oncology bundles for the first time this year, launched at the 2022European Congress of Radiology. Onsite at the conference, attendees were able to view bundles, which combine components that have been tested and verified to work together so clinicians can offer state-of-the-art onboardCone Beam CT(CBCT) in facilities. As cancer cases rise globally, an estimated 60% of new patients will need some form of radiation therapy, but only 25% of those patients will receive treatment, either because the equipment is not available or because treatment is too costly. It is estimated that by 2030, if every patient who needsradiotherapy如果能够获得它,每年全世界将有近100多万人的生命得到拯救。图像引导是使放射治疗更精确的一个重大突破,因为它使医生能够在治疗前立即拍摄图像,而患者处于治疗位置。

Theoncologybundles include:

· X-ray Tubes, which customers rely on our products’ small focal spot size to enable high resolution imaging

· X-ray Flat Panel Detectors, providing excellent soft tissue visualization to identify tumor borders, a large field of view, fast frame speed of up to 150 frames-per-second, sharp images, and minimal motion artifacts

· Anti-scatter Grids, which significantly improve soft tissue visibility and uniformity without the need to increase imaging dose

· Cables, including all modifications customers need for efficient integration into their linear accelerator

Dunlee offers two types of bundles, that combine successful and proven imaging solutions with the specific needs of image guidance in therapy.:

·DA1094 X-ray Tube Bundle, which consists of a flat panel detector, DA 1094 X-ray tube, anti-scatter grid and high voltage cables

· Grid and Detector Bundle, which combines a state-of-the-art anti-scatter grid with theDunlee XD-300 Detectorfor excellent soft tissue visualization and fast operation

· Dunlee Solutions+, Dunlee’s service portfolio, which supports customers in every step of product development, from system definition through operation

For more information:https://www.dunlee.com/

Find more ECR22 coverage here

Related Content

Research has potential to address significant unmet need, identify biomarkers that determine response to treatment
News|Lung Imaging

August 10, 2022 — Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 ...

TimeAugust 10, 2022
arrow
Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD software to significantly improve the accuracy and speed of prostate cancer detection (CADe) and diagnosis (CADx).
News|Prostate Cancer

August 9, 2022 — Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD ...

TimeAugust 09, 2022
arrow
The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with unresectable (unable to be removed) or metastatic (spread to other parts of the body) HER2-low breast cancer.
News|2022世界杯篮球预选赛赛程

August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...

TimeAugust 08, 2022
arrow
Dr. Milena Cavic, Institute for Oncology and Radiology of Serbia
News|Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

TimeAugust 08, 2022
arrow
David Gerber, MD
News|Lung Imaging

August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...

TimeAugust 08, 2022
arrow
Under this collaboration, IBA will equip the proton therapy system and the proton gantry treatment room at the Fred Hutchinson Cancer Center with ConformalFLASH research functionality, which will enable preclinical research on FLASH therapy.
News|Proton Therapy

August 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

TimeAugust 05, 2022
arrow
Chest with AI Brightness and Contrast (AIBC), using Helix 2.2 Advanced Imaging Processing.
News|X-Ray

August 5, 2022 — GE Healthcare released its most advanced fixed X-ray system yet, the next-generation Definium 656 HD ...

TimeAugust 05, 2022
arrow
Enhancing oncology model aims to improve patient-centered care, lower health care costs, and address health equity as part of President Biden’s Cancer Moonshot
News|Radiology Business

August 4, 2022 — The Biden Administration, through the U.S. Department of Health and Human Services and the Centers for ...

TimeAugust 04, 2022
arrow
Xoran Technologies announces that last month it received FDA 510(k) clearance for TRON — a truly mobile, full-body fluoroscopy, computed tomography (CT) X-ray system.
News|Computed Tomography (CT)

August 4, 2022 — Xoran Technologies announces that last month it received FDA 510(k) clearance for TRON — a truly mobile ...

TimeAugust 04, 2022
arrow
EHR screenshot showing sidebar text displayed to referring clinicians after placing orders for body CT (neck, chest, or abdomen and pelvis), describing iohexol shortage and providing appropriate strategies for iodinated contrast media conservation.
News|Contrast Media

August 3, 2022 — According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), electronic health ...

TimeAugust 03, 2022
arrow
Subscribe Now